ridges and less within the furrows of the dermatoglyphs. Subsequent histopathologic analysis of those lesions demonstrated atypical melanocytes containing melanin granules within the crista profunda intermedia. 6 Similarly, in their retrospective analysis of Japanese patients with melanocytic lesions, Saida et al 5 found the parallel ridge pattern more diagnostically accurate of melanoma in situ than "irregular diffuse pigmentation." 5(p1235) Melanocytic nevi, subcorneal hemorrhage, exogenous pigmentation, and lentiginosis and drug-induced hyperpigmentation can demonstrate a dermoscopic parallel ridge pattern. 3 Benign dermoscopic attributes include a parallel furrow pattern, 5 a lattice-like pattern, 6 and/or the lack of disruption of the acrosyringia within the epidermal ridges. 3 Our patient's history suggested recent onset, an uncommon feature in ALM. Because we did not specifically inquire about exogenous pigment exposures, our initial evaluation failed to reveal information that may have allowed for earlier exclusion of ALM. Our case serves as a reminder to clinicians of the importance of a thorough history. Exogenous tissue dyeing should be considered in the differential diagnosis of acral pigmented lesions, particularly if the clinical history suggests the lesion is of recent onset.
Transarterial chemoembolization (TACE) with drug-eluting microspheres (DEMs) is emerging as the therapy of choice by many interventional oncologists and radiologists for unresectable liver tumors. Improvements in drug delivery systems have been made by modification of the embolic agents and the introduction of microcatheters, allowing for precise drug delivery to tumors. Currently, DEMs are being used as the drug delivery system for TACE. 1 We report herein a case of cutaneous embolization of doxorubicinimpregnated DEMs after DEM TACE treatment for breast carcinoma metastasized to the liver.
Report of a Case | A woman in her 60s with a history of metastatic breast carcinoma presented with a painful pruritic erup- A, Shave biopsy specimen from the acral lesion demonstrates no significant changes (hematoxylin-eosin, original magnification ×40). Fontana staining confirmed absence of melanin hyperpigmentation; Perls stain was nonreactive for hemosiderin; periodic acid-Schiff, Steiner, and Giemsa preparations were nonreactive for infectious microorganisms (not shown). B, Review of ex vivo dermoscopic image obtained at the time of tissue trimming demonstrated an irregular patch of yellow-brown discoloration with slight accentuation at sweat duct openings; no parallel ridge pattern was evident.
Letters tion on her abdomen. One week earlier, she had undergone doxorubicin DEM TACE treatment for liver metastasis with doxorubicin DEM (100-300 μm/75 mg doxorubicin) (LC Beads; Biocompatibles UK Ltd). On physical examination, her right abdominal skin had tender reticulate erythematous nodules coalescing into plaques. Laboratory abnormalities were noted, including a white blood cell count of 17 700/μL and elevated transaminase levels (to convert white blood cells to ×10 9 /L, multiply by 0.001). Punch biopsy histologic findings were consistent with a drug reaction characterized by a lymphocytic infiltrate with eosinophils in the reticular dermis. At 1 week follow-up, her symptoms persisted with some skin ulceration (Figure, A) , and an excisional biopsy was performed.Histologicanalysisshowedpurpleforeignmaterialpresent within vessels and inflammation with focal necrosis within the adipose tissue (Figure, B) . No fibrin clots or malignant cells were noted. An embolic process of the doxorubicin pellets in the vessels of the adipose tissue was suspected.
The excisional biopsy specimens and DEM were submitted for x-ray analysis. The element and atomic percentages were noted. The doxorubicin DEM showed carbon (65.77%), oxygen (27.91%), sulfur (1.88%), sodium (3.52%), and chloride (0.92%) elements. The skin specimen revealed carbon (76.2%), oxygen (20.14%), sodium (2.89%), and scant sulfur (0.77%) content. The sodium from the skin specimen likely corresponded to the sodium chloride within the microspheres. The finding of similar atomic percentages between the same elements in both samples supports the idea that the beadlike material visible in the skin and the DEM were from the same source. Our patient's pruritus was treated with lidocaine cream; her skin lesions improved; and her laboratory findings returned to baseline.
Discussion | The advantages of DEM TACE include delivery of higher doses of chemotherapy and prolonged tumor contact time while reducing the systemic toxic effects of chemotherapeutic agents. 2 DEM TACE is being used for treatment of unresectable hepatocellular carcinoma, metastatic breast cancer, metastatic colon cancer, neuroendocrine tumors, cholangiocarcinoma, and metastatic melanoma, among others. 2,3 The most common adverse effects after the procedure are nausea, vomiting, pain, and elevated transaminase levels. 4 Embolic agents have improved dramatically with the development of microspheres. Embolization with microspheres alone is approved by the US Food and Drug Administration for hypervascular tumors and arteriovenous malformations. DEMs are being used for chemoembolization of malignant tumors. Microspheres are hydrophilic, and the size is precisely calibrated. 5 There are 2 commercially available DEMs: DC/LC Beads (Biocompatibles UK Ltd) and HepaSphere (Biosphere Medical Inc). 2,5 The negative charge on both of these microspheres allows positively charged drugs like doxorubicin or irinotecan to be loaded into the beads. 5 Then, prior to injection of the doxorubicin DEM, an angiogram is performed to evaluate degree of hepatic tumor perfusion and extrahepatic perfusion. 4 A microcatheter is then positioned for injection of the doxorubicin DEM, and the drug is delivered. 2 The patient described herein represents a case of cutaneous embolization of DEM. We hypothesize that embolization into the subcutaneous fat occurred through the development of collateral vasculature in our patient. We suspect that this will become more common as smaller DEMs are being used for treating tumors.
